Expert discussed benefits of precision oncology treatments that utilize thousands of biomarkers to design personalized treatment plans ..read more

Dr. Amina Abubakar is CEO at Avant Pharmacy and Wellness. You can connect with her on LinkedIn here. Dr. Stephen Lewis, FAAPMR, is National Medical Director of the Physiatry-Pharmacy Collaborative (PPC). You can connect with him on LinkedIn here. The Avant Institute annual symposium will take place January 31st to February 1st, 2025, in Charlotte, North Carolina at Queens University. To learn more about the institute, the resources they offer, and details about the symposium, you can access their website here. You can follow Avant Institute on LinkedIn here ..read more

Expert discussed the potential of pelareorep, a novel immunotherapeutic agent, in treating advanced or metastatic breast cancer, particularly in HR-positive, HER2-negative patients, and the plans for further clinical development of pelareorep in this indication ..read more

Christina Madison, PharmD, FCCP, AAHIVP, sat down with Amy Marie Merrell, to discuss current issues within sexual health ..read more

Thomas Chen, MD, PhD discussed his innovative approach to brain cancer treatment through NeOnc, Inc.  ..read more

In this episode, host Dr. Christina Madison interviews Jessica Steier, DrPH, PMP, CEO of Vital Statistics Consulting, and the founder and CEO of Unbiased Science, on her journey in public health and entrepreneurship. In a period of misinformation and disinformation, both Madison and Steier discuss the importance of creating informed, evidence-based decisions within health care. Key Takeaways: Data-Based and Evidence-Informed Decisions: Using her podcast, Unbiased Science, Dr. Jessica Steier explains that she doesn’t intend to tell people what scientific opinions to have. Instead, she encoura ..read more

Expert shares reasons why many women are behind on their annual breast cancer screenings, along with the latest cutting edge treatment in the breast cancer space.  ..read more

The Alzheimer disease treatment landscape is rapidly changing, with several new FDA-approved antibody therapies that target amyloid plaque and aim to slow disease progression. While the controversial approval of aducanumab faced challenges, newer drugs like lecanemab and donanemab have shown more promising results in clinical trials, demonstrating cognitive benefits. Additionally, the pipeline includes novel therapies targeting tau protein and other mechanisms. Advancements in biomarker development, including plasma and imaging tests, are also enabling earlier diagnosis and the potential for p ..read more

In this episode, host Dr. Christina Madison interviews the co-CEOs of Healthcare Advocate Summit Melissa Paige, BPHM, CPhT, MTM, president of National Association of Medication Access & Patient Advocacy (NAMAPA), and Elizabeth Johnson, CEO of MedicoCX, and president and co-founder of NAMAPA on Healthcare Advocate Summit and its mission. They describe how collaboration, education, and advocacy can go a long way in improving access to medications and health care. Key Takeaways: Medication Access: Medication access is a complex, systemic issue. The high cost of medication is a significant b ..read more

Olivia Kinney, PharmD, a national pharmacy practice manager at Kroger, emphasized the importance of pharmacists addressing the growing issue of vaccine hesitancy. She noted that common reasons for hesitancy include concerns about adverse effects, misinformation, access barriers, and social/political influences. Kinney advised that pharmacists can build trust by actively listening to patients' concerns, providing relevant and consistent education, and leveraging their position as trusted healthcare providers. She highlighted the value of pharmacists is in collaborating with other community orga ..read more